Table 6 In-hospital follow-up data in the propensity-score matched (PSM) population.
PSM population | Cangrelor | Non Cangrelor | p | ||||
|---|---|---|---|---|---|---|---|
n = 356 | (%) | n = 178 | (%) | n = 178 | (%) | ||
Contrast induced nephropathy | 10 | (2.8) | 7 | (3.9) | 3 | (1.7) | 0.168 |
All-cause death | 26 | (7.3) | 17 | (9.6) | 9 | (5.1) | 0.103 |
Any bleedings | 11 | (3.1) | 5 | (2.8) | 6 | (3.4) | 0.759 |
Any ischemic cerebro-cardiovascular complications* | 11 | (3.1) | 3 | (1.7) | 8 | (4.5) | 0.126 |
Myocardial infarction | 10 | (2.8) | 3 | (1.7) | 7 | (3.9) | 0.168 |
Periprocedural myocardial infarction | 9 | (2.5) | 3 | (1.7) | 6 | (3.4) | 0.251 |
Definite/probable stent thrombosis | 6 | (1.7) | 1 | (0.6) | 5 | (2.8) | 0.107 |
Definite stent thrombosis | 5 | (1.4) | 0 | (0.0) | 5 | (2.8) | 0.030 |
Probable stent thrombosis | 1 | (0.3) | 1 | (0.6) | 0 | (0) | 0.500 |
BARC bleeding ≥ 3a | 10 | (2.8) | 5 | (2.8) | 5 | (2.8) | 1.000 |
TIMI major bleeding | 3 | (0.8) | 2 | (1.1) | 1 | (0.6) | 0.500 |
TIMI at least minor bleeding | 7 | (2) | 5 | (2.8) | 2 | (1.1) | 0.224 |
ISTH major bleeding | 8 | (2.2) | 4 | (2.2) | 4 | (2.2) | 0.638 |
GUSTO severe bleeding | 1 | (0.3) | 1 | (0.6) | 0 | (0) | 0.500 |
GUSTO at least moderate bleeding | 9 | (2.5) | 5 | (2.8) | 4 | (2.2) | 0.500 |
